
Biostax
(OTC) IMUN
Biostax Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$0.00
Net Income (TTM)
$934.00K
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
IMUN News
IMUN: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Biostax
Industry
Biotechnology
Sector
Health CareCEO
Noreen M. Griffin
Website
www.biostaxcorp.comHeadquarters
Winter Park, FL 32792, US
IMUN Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
67%
Return on Capital
33%
Return on Assets
-67%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$0.00
Operating Income
$1.16M
EBITDA
$643.00K
Operating Cash Flow
$581.82K
Capital Expenditure
$500.00K
Free Cash Flow
$1.08M
Cash & ST Invst.
$150.49K
Total Debt
$696.48K
Biostax Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
N/A
N/A
Net Income
$0.00
+100.0%
EBITDA
$0.00
+100.0%
Quarterly Fundamentals
Net Cash
$1.17M
-114.4%
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$0.00
N/A
Short Term Debt
$1.17M
+68.0%
Return on Assets
-66.96%
N/A
Return on Invested Capital
32.80%
N/A
Free Cash Flow
$11.06K
+102.5%
Operating Cash Flow
$11.06K
+102.5%